ETV1 and posterior cortical atrophy: To expand the validation of the potential efficacy of Erlotinib and TTI‐101 combination in advanced PCa, we performed synergistic analysis and growth impairment studies in 3D cell models of LNCaP and VCaP cells, as cell models of advanced ETV1‐ and ERG‐driven oncogenic signaling, respectively.